The FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential approval, which the company said it would do.
Investing was hot earlier in the pandemic, but not anymore. Analysts share with CNBC Make It their top investing tips for a volatile market.
Spare seats were hard to find for many travelers because flights were so full and schedules limited.
The Federal Aviation Administration has launched an investigation after two commercial airplanes narrowly avoided a collision at John F. Kennedy International Airport on Friday.
A majority of Americans 25 and older haven’t completed a bachelor’s degree. If you’re one of them, here’s how to format your resume.
Pfizer’s CEO was among the more than 200 pharmaceutical company executives who signed the letter after a federal judge’s controversial ruling on mifepristone.
What investors need to know about ‘staking,’ the passive income opportunity at the center of crypto’s latest regulation scare.
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
 contributions will jump nearly 10% in 2023, but it’s not always a good idea to max out your retirement investments')){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}